Skip to content

Development and promotion of individualized tobacco dependence intervention technologies

Development and promotion of individualized tobacco dependence intervention technologies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068679
Enrollment
Unknown
Registered
2023-02-27
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Dependence

Interventions

Varenicline:N/A
Bupropion:N/A
Nicotine Replacement Therapy:N/A

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-85 years; 2. Smoking age >=5 years, daily smoking >=10 cigarettes in the past 12 months; 3. Exhalation carbon monoxide detection >=10 ppm at baseline assessment; 4. Willing to accept smoking cessation treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic to nicotine, vaxicline, bupropion or similar components; 2. Received other smoking cessation treatments within 30 days; 3. Pregnant or lactating women; 4. Hypertension patients with severe heart, lung, brain, and blood system diseases, including but not limited to acute myocardial infarction within 2 weeks, severe arrhythmia, unstable angina, and poorly controlled medications; 5. suffering from mental illness and drug addicts; 6. there are maxillofacial diseases can not use chewing gum; 7. Other diseases or mental states that cannot meet the requirements of the study as judged by the researcher.

Design outcomes

Primary

MeasureTime frame
9-12 week sustained abstinence rate verified by exhaled carbon monoxide;

Countries

China

Contacts

Public ContactXiao Dan

China Japan Friendship Hospital

danxiao@263.net010-84205425

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026